We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $12.3M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
+53.81%
1 Year Est. Return
-3.13%
3 Year Est. Return
+108.96%
5 Year Est. Return
-90.91%
10 Year Est. Return
–
AUM
$15M
AUM Growth
-$3.63M
Cap. Flow
-$10M
Cap. Flow %
-66.65%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CBLL
CeriBell Inc
CBLL
+$10M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBLL
1
CeriBell Inc
CBLL
$714M
$9.69M 64.38%
441,820
-646,281
-59% -$10M
RPID icon
2
Rapid Micro Biosystems
RPID
$86.2M
$5.36M 35.62%
1,848,296
– –

Similar funds

M
MetLife New York $12.3M AUM 29% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
IWM
Immaculate Wealth Management Mesa, Arizona $12.7M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, ABG-WTT Global Life Science Capital Partners held 2 positions worth $15M, down 19% from $18.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG-WTT Global Life Science Capital Partners withdrew a net $10M in Q4 2025, reducing 1 holding. Its largest reduction was CeriBell Inc, cutting an estimated $10M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG-WTT Global Life Science Capital Partners's biggest Q4 2025 reduction was CeriBell Inc, cutting an estimated $10M.
  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $15M portfolio in Q4 2025.
  • ABG-WTT Global Life Science Capital Partners opened 0 new positions and closed 0 in Q4 2025.
  • ABG-WTT Global Life Science Capital Partners's portfolio value fell 19% quarter-over-quarter to $15M.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.